Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.86 USD | +1.69% | -0.73% | -0.28% |
Apr. 30 | Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on February 29, 2024. | CI |
Apr. 30 | Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on November 1, 2023. | CI |
Business Summary
Number of employees: 1,100
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Related Supplies
68.1
%
| 115 | 72.5 % | 126 | 68.1 % | +9.44% |
Electrotherapy Devices
31.9
%
| 43 | 27.5 % | 59 | 31.9 % | +35.23% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
100.0
%
| 158 | 100.0 % | 184 | 100.0 % | +16.54% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Sandgaard
CEO | Chief Executive Officer | 65 | 95-12-31 |
Daniel Moorhead
DFI | Director of Finance/CFO | 51 | 17-06-04 |
Anna Lucsok
COO | Chief Operating Officer | 38 | 18-01-31 |
Steve Fox
SAM | Sales & Marketing | - | 19-12-31 |
Dave Anttila
HRO | Human Resources Officer | - | 18-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Barry Michaels
BRD | Director/Board Member | 74 | 18-01-09 |
Thomas Sandgaard
CEO | Chief Executive Officer | 65 | 95-12-31 |
Michael Cress
BRD | Director/Board Member | 66 | 18-01-09 |
Joshua Disbrow
BRD | Director/Board Member | 49 | 18-03-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,442,062 | 15,437,468 ( 37.25 %) | 9,666,879 ( 23.33 %) | 37.25 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.28% | 339M | |
+12.06% | 225B | |
+12.07% | 186B | |
+13.88% | 135B | |
+27.12% | 107B | |
+0.91% | 63.56B | |
+6.74% | 51.32B | |
+13.39% | 51.04B | |
+8.81% | 43.3B | |
+4.14% | 36.99B |
- Stock Market
- Equities
- ZYXI Stock
- Company Zynex, Inc.